Chargement en cours...
Dual inhibition of PI3Kα and mTOR as an alternative treatment for Kaposi's sarcoma
Rapamycin (or sirolimus), the prototypical inhibitor of the mammalian target of rapamycin (mTOR) and an immunosuppressant used for the prevention of renal transplant rejection, has recently emerged as an effective treatment for Kaposi's sarcoma (KS), an enigmatic vascular tumor and a model for...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2008
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2645787/ https://ncbi.nlm.nih.gov/pubmed/18922908 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-08-0878 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|